Intermountain Healthcare Partners With GYANT to Co-Develop on COVID-19 Screener and Emergency Response Solution

Virtual assistant offers COVID-19 information and triage support for Intermountain patients

GYANT, the patient connection and relationship management company, announced that Intermountain Healthcare is now deploying a jointly developed COVID-19 Screener and Emergency Response Assistant (COVID-19 SERA), created in collaboration with Intermountain infectious disease clinicians. The automated chat solution, available via Intermountain Healthcare’s homepage, offers screening and care navigation support for all Intermountain Healthcare patients, and answers questions related to symptoms and prevention.

“Health systems and hospital resources are more strained than ever before”

With the COVID-19 SERA, Intermountain patients now have access to the most current information about the spread of COVID-19 from the Centers for Disease Control and Prevention (CDC) and Intermountain infectious disease clinicians. The solution screens for COVID-19 symptoms and risk factors, and based on patients’ responses, directs them to the most appropriate medical settings. It is also equipped with tips and recommendations to help educate patients and prevent further spread of COVID-19. Intermountain is delivering all of this information via a highly customized version of GYANT’s COVID-19 SERA, branded as ‘Scout.’

Recommended AI News: Viventium Named FrontRunner for Payroll Software

“At Intermountain, we’re committed to keeping our patients informed and giving them access to the tools and support they need during this critical time,” said Kevan Mabbutt, Intermountain Healthcare’s chief consumer officer. “That’s why we worked with GYANT to develop ‘Scout,’ a friendly virtual assistant that provides on-demand screening and answers to our community’s COVID-19-related questions. ‘Scout’ is especially important with COVID-19 because it helps people get symptoms checked out quickly and easily while social distancing at home and prioritizes testing and telehealth resources for those who need them most.”

Since the deployment of COVID-19 SERA, Intermountain has seen more than 157,000 users in 2.5 weeks, with an average of about 9,300 per day. The tool has conducted COVID-19 screenings for Intermountain patients with a 93% screening completion rate. Intermountain has also seen a 30% decrease in call center volume, which helps alleviate strain on the call center and opens up lines of patient-clinician communications for those who need it most.

Recommended AI News: Universal Robots Launches ActiNav, the World’s First Autonomous Bin Picking Kit for Machine Tending Applications

“Health systems and hospital resources are more strained than ever before,” said Stefan Behrens, CEO and co-founder, GYANT. “We launched our COVID-19 SERA with the intention of easing the burden on hospital resources. With ‘Scout,’ Intermountain can offer patients the information they need virtually, keeping healthy people home and directing non-emergent patients to telehealth, keeping patients in their homes when appropriate and limiting the risk of exposure for both patients and providers.”

Intermountain’s instance of the COVID-19 Screener and Emergency Response Assistant will continuously update based on guidelines from the Centers for Disease Control and Prevention and Intermountain infectious disease clinicians.